Validation of a Salivary miRNA Signature of Endometriosis - Interim Data.

NEJM evidence(2023)

引用 3|浏览6
暂无评分
摘要
Salivary miRNA Signature of EndometriosisThis interim analysis of the prospective, multicenter, external validation ENDOmiRNA Saliva Test study, confirms the diagnostic performance and reproducibility of the saliva miRNA signature for endometriosis. At a population prevalence of ∼80%, the miRNA signature had a sensitivity of 96.2%, specificity of 95.1%, and area under the curve of 0.96.
更多
查看译文
关键词
endometriosis,mirna signature,salivary
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要